NEW YORK, Oct. 30 – Genzyme was given the green light from a court in Belgium to acquire rival Pharming NV, currently in receivership, Genzyme said on Tuesday.

Pharming Group, the subsidiary’s parent company, said it plans to appeal the ruling. In September, the company said it opposed an offer from Genzyme because the bid was too low.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.